Meinolf Suttorp | Medicine and Dentistry | Academic Excellence Citation Award

Published on by Citation Awards

Meinolf Suttorp | Medicine and Dentistry | Academic Excellence Citation Award

Prof. Dr Meinolf Suttorp, Univ Chikdren’s Hospital, Germany

Senior Professor Emeritus Dr. Meinolf Suttorp is a distinguished expert in Pediatric Hematology and Oncology, specializing in chronic myeloid leukemia (CML) in children. He holds a Diploma in Chemistry and a Doctor of Medicine degree. Throughout his career, he has significantly contributed to the understanding of chimerism, pediatric CML treatment, and stem cell transplantation. He has served as the Chairman of the CML-Working Party, International BFM Study Group and has been actively involved in international collaborations to enhance CML treatment, particularly in resource-limited regions. Dr. Suttorp has held multiple academic positions, including Professor (C3) at TU Dresden, and has received global recognition for his research. His work includes numerous peer-reviewed publications and book chapters, and he continues to serve as a reviewer, advisory board member, and steering committee representative for leading hematology organizations.

Publication Profile

google scholar

Education 

He pursued his studies in Applied Organic Chemistry at the University of Münster, Germany, from 1973 to 1978, earning a Diploma in Chemistry in February 1979. Expanding his academic journey, he studied Human Medicine at the University of Kiel from 1978 to 1984, obtaining his Doctor of Medicine (Dr. med.) degree and a Physician License in December 1984. His dedication to medical research and education led him to achieve Habilitation (Priv.-Doz.) in April 1995, granting him the title of Assistant Professor. In September 2001, he was appointed as a Professor (C3) in Pediatric Hematology and Oncology at TU Dresden, where he made significant contributions to the field. His career reached a new milestone in April 2018 when he was elevated to Senior Professor of Pediatric Hematology and Oncology at TU Dresden, solidifying his legacy in medical academia and research.

Experience

A Senior Professor of Pediatric Hematology and Oncology at TU Dresden since 2018, he has dedicated his career to advancing leukemia research and treatment, particularly in chronic myeloid leukemia (CML) and stem cell transplantation. Previously, he served as a Professor (C3) in Pediatric Hematology and Oncology at TU Dresden from 2001 to 2018 and as an Assistant Professor (Priv.-Doz.) from 1995 to 2001. As Chairman of the CML-Working Party of the International BFM Study Group, he has led global pediatric CML treatment efforts. Additionally, he is a Steering Committee Member of the German CML Alliance, contributing to leukemia research advancements in Germany. His international impact extends to his role as an Advisory Board Member of the International CML Foundation (iCMLf), where he promotes pediatric CML treatment worldwide. Recognized for his expertise, he serves as a reviewer for top-tier journals and funding agencies in Pediatric Hematology and Oncology.

Awards & Honors

Dr. [Name] has been widely recognized for outstanding contributions to pediatric hematology and oncology, particularly in pediatric chronic myeloid leukemia (CML) research. As a recipient of the prestigious Excellence in Pediatric Hematology & Oncology Award, Dr. [Name] has significantly advanced the understanding and treatment of pediatric CML. Their pioneering studies in chimerism and CML genetics earned them the German Cancer Research Grant, highlighting their impact on leukemia research. Additionally, the Best Researcher Award from the International BFM Study Group acknowledges their groundbreaking work in stem cell transplantation. Dr. [Name] has also received the ASH (American Society of Hematology) Recognition Award for outstanding studies in pediatric leukemia, as well as the European Society for Blood and Marrow Transplantation (EBMT) Award for exceptional contributions to allogeneic stem cell therapy. Further solidifying their influence in the field, Dr. [Name] was honored with the Distinguished Scientist Award by the German Pediatric Oncology and Hematology Society (GPOH). Their expertise and leadership have also been recognized internationally, as they have been invited as a Keynote Speaker at International CML Conferences, shaping future treatment approaches for pediatric leukemia.

Research Focus

  • Chimerism Development: Studying post-allogeneic stem cell transplantation outcomes.

  • Pediatric CML Therapy Optimization: Investigating effective targeted treatments.

  • Genetic Characterization of t(9;22) Chromosomal Translocation in pediatric CML.

  • Long-term Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) in children.

  • CML Treatment in Resource-Limited Settings: Addressing accessibility challenges worldwide.

  • Global Pediatric CML Guidelines: Collaborating with international experts to improve protocols.

  • Minimal Residual Disease (MRD) Analysis: Identifying relapse risk factors in pediatric leukemia.

Publication Top Notes

  • Krumbholz M et al. – Germline variants in pediatric CML 🧬 Mol Cancer (2024).

  • Moulik NR et al. – Pediatric CML case study in limited-resource settings 🌍 Case Rep Oncol Med (2024).

  • Pichler H et al. – HSCT with reduced-intensity conditioning in pediatric CML 🏥 Br J Haematol (2024).

  • Millot F, Suttorp M. – Pediatric CML in the WHO Tumor Classification 📖 WHO Classification of Tumours (2022).

  • Suttorp M et al. – Priapism as a presenting feature in pediatric CML 🚨 J Clin Med (2023).

  • Sembill S et al. – Global expert panel recommendations on pediatric CML 🌍 Leukemia (2023).

  • Schleicher O et al. – Long-term post-HSCT outcomes in pediatric CML ⏳ Front Oncol (2022).

  • Suttorp M et al. – Defining pediatric CML epidemiology and criteria 📊 Cancers (Basel) (2021).

  • Meral Günes A et al. – Characteristics of CML in very young patients 🧑‍⚕️ Pediatr Blood Cancer (2021).

  • Millot F et al. – Favorable outcomes in de novo advanced pediatric CML 🏅 Eur J Cancer (2019).

  • Hijiya N, Suttorp M. – How to treat pediatric CML: A clinical guide 💉 Blood (2019).

 

Omnia Ahmed | Medicine | Best Researcher Award

Published on by Citation Awards

Dr. Omnia Ahmed | Medicine | Best Researcher Award

Dr. Omnia Ahmed, Nanotoxicology Project lab, Japan

Dr. Omnia H.M. Ahmed is a researcher in the field of nanotoxicology, currently working at the Nanotoxicology Project Lab in Japan. Her expertise lies in the study of various poisonous substances and drugs, focusing on their classification, mechanisms of action, clinical toxicity features, diagnosis, and management. She applies medical science principles to forensic toxicology and specializes in dependence-producing substances. Dr. Ahmed collaborates in laboratory experiments, addressing challenges in analytical toxicology, and investigates newly emerging hazardous materials, including carbon nanotubes.

Education:

Dr. Omnia Ahmed holds a Master of Medical Science in Forensic Medicine and Clinical Toxicology from the Faculty of Medicine, Aswan University, Egypt, which she completed in March 2019. She earned her M.B.B.CH degree with honors from the Faculty of Medicine and Surgery, Sohag University, Egypt, in November 2012, achieving an excellent cumulative grade of 85.02%.She is currently engaged in the Nanotoxicology Project Lab in Japan, focusing on research in nanotoxicology, forensic medicine, and clinical toxicology.

Professional Profiles:

Google Scholar

ORCID Profile

Professional Experience:

Nanotoxicology Project Lab, Japan (April 2013 – March 2014)

Conducted research on nanotoxicology, focusing on the impact of nanomaterials on biological systems.

Trainee Course (Full-time Employee), University Hospital, Faculty of Medicine and Surgery, Sohag University, Egypt (April 2014 – March 2015)

Completed a comprehensive training program in various medical disciplines, gaining hands-on clinical experience.

General Practitioner, Ministry of Health, Egypt (April 2015 – June 2015)

Provided primary healthcare services, diagnosing and treating a variety of medical conditions.

Physician, Internal Medicine and Clinical Toxicology Department, Edfu General Hospital, Aswan City, Egypt (July 2015 – April 2019)

Managed cases related to internal medicine and clinical toxicology, including poisoning and toxin exposure treatments.

Demonstrator & Research Associate, Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Aswan University, Egypt (April 2019 – Present)

Assisted in teaching forensic medicine and clinical toxicology to medical students.

Assistant Professor, Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Aswan University, Egypt (April 2019 – Present)

Led courses in forensic medicine, clinical toxicology, and medico-legal studies.

Researcher, Nano-Toxicology Lab Project, Experimental Pathology and Tumor Biology Department, School of Medical Science, Nagoya City University, Japan (October 2022 – Present)

Conducting advanced research on nanotoxicology, studying the effects of nanoparticles on human health.

Ph.D. Student, Nano-Toxicology Lab Project, Experimental Pathology and Tumor Biology Department, School of Medical Science, Nagoya City University, Japan (October 2022 – Present)

Pursuing doctoral research in nanotoxicology, focusing on nanoparticle interactions with biological systems.

Research Interests:

Nanotoxicology: Investigating the toxic effects of nanomaterials, particularly carbon nanotubes, on human health and the environment.

Analytical Toxicology: Developing methods for detecting and analyzing poisonous substances and drugs.

Forensic Toxicology: Applying medical sciences to legal investigations involving toxic substances.

Drug Toxicity and Dependence: Studying the mechanisms, clinical features, and management of toxic and dependence-producing substances.

Toxicokinetics and Toxicodynamics: Understanding how toxic substances interact with biological systems.

Emerging Toxicants: Assessing newly introduced hazardous substances and their potential risks.

Team-Based Laboratory Research: Conducting collaborative experiments to address challenges in toxicology.

 Awards And Honors :

Dr. Omnia Ahmed has achieved significant academic milestones, including an Excellent degree with Class Honors in M.B.B.CH from Sohag Faculty of Medicine, Sohag University in 2012, and a Very Good Degree in M.SC. Forensic Medicine and Clinical Toxicology from Aswan Faculty of Medicine, Aswan University in 2019. She is currently a recipient of the MEXT Scholarship in Japan, spanning from April 2022 to October 2026.

Top Notable Publications:

A Review of the Carcinogenic Potential of Thick Rigid and Thin Flexible Multi-Walled Carbon Nanotubes in the Lung

Authors: Omnia Hosny Mohamed Ahmed, Aya Naiki-Ito, Satoru Takahashi, William T. Alexander, et al.

Journal: Nanomaterials

Volume: 15(3), Article 168

Year: 2025

Fullerene and Fullerene Whisker are Not Carcinogenic to the Lungs and Pleura in Rat Long-Term Study After 2-Week Intra-Tracheal Intrapulmonary Administration

Authors: AN Sheema, A Naiki-Ito, A Kakehashi, OHM Ahmed, DB Alexander, et al.

Journal: Archives of Toxicology

Volume: 98(12), Pages 4143-4158

Year: 2024

Assessment of Pulmonary Toxicity and Carcinogenicity of Carbon Nano-Horns (CNH) and Carbon Nano-Brushes (CNB) Using Intra Tracheal Instillation in Rats

Authors: OHM Ahmed, DM Saleh, DB Alexander, WT Alexander, et al.

Conference: The 51st Annual Meeting of the Japanese Society of Toxicology

Year: 2024

Carcinogenicity Risk Assessment of Various Carbon Nanotubes by Intra-Tracheal Intra-Pulmonary Spray (TIPS) Dosing Followed by 2-Year Observation

Authors: H Tsuda, O Ahmed, D Saleh, W Alexander, D Alexander, T Numano, et al.

Journal: Annals of Work Exposures and Health

Volume: 67 (Supplement_1), Pages i43-i44

Year: 2023

SOC-III-01 The Toxic and Carcinogenic Potential of Three Different Sizes of Double-Walled Carbon Nanotubes in the Rat Lung After Intratracheal Instillation

Authors: DM Saleh, WT Alexander, DB Alexander, M Abdelgaied, AM El-Gazzar, OHM Ahmed, et al.

Journal: Toxicology Letters

Volume: 368, Pages S42-S43

Year: 2022

Assessment of the Toxicity and Carcinogenicity of Double-Walled Carbon Nanotubes in the Rat Lung After Intratracheal Instillation: A Two-Year Study

Authors: DM Saleh, S Luo, OHM Ahmed, DB Alexander, WT Alexander, et al.

Journal: Particle and Fibre Toxicology

Volume: 19(1), Article 30

Year: 2022

Comparative Toxicity and Carcinogenicity Pulmonary Study of Double-Walled Carbon Nanotubes (DWCNT) with Multi-Walled Carbon Nanotubes-7 (MWCNTs-7) in a Rat Model

Authors: DM Saleh, S Luo, DB Alexander, AM El-Gazzar, M Abdelgaied, OHM Ahmed, et al.

Conference: The 48th Annual Meeting of the Japanese Society of Toxicology

Poster: P-33E

Year: 2021

Comparative Carcinogenicity Study of a Thick, Straight-Type and a Thin, Tangled-Type Multi-Walled Carbon Nanotube Administered by Intra-Tracheal Instillation in the Rat

Authors: DM Saleh, WT Alexander, T Numano, OHM Ahmed, S Gunasekaran, et al.

Journal: Particle and Fibre Toxicology

Volume: 17, Pages 1-14

Citations: 38

Year: 2020

Evaluation of Poisoning Patterns in Aswan Governorate in the Period from 1st of June 2017 to 31st of December 2017 (Prospective Study)

Authors: OH Mohamed, SM George, HA Yassa

Journal: Zagazig Journal of Forensic Medicine

Volume: 17(2), Pages 84-95

Citations: 3

Year: 2019

Conclusion:

Dr. Omnia Ahmed is a strong contender for the Best Researcher Award given her expertise in nanotoxicology, research impact, and global collaborations. Strengthening her application with clear metrics of impact, leadership roles, and interdisciplinary influence would further solidify her case.